FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact

Center for Computational Systems Medicine
leaf

FusionGeneSummary

leaf

FusionProtFeature

leaf

FusionGeneSequence

leaf

FusionGenePPI

leaf

RelatedDrugs

leaf

RelatedDiseases

Fusion gene ID: 41453

FusionGeneSummary for VHL_TATDN2

check button Fusion gene summary
Fusion gene informationFusion gene name: VHL_TATDN2
Fusion gene ID: 41453
HgeneTgene
Gene symbol

VHL

TATDN2

Gene ID

7428

9797

Gene namevon Hippel-Lindau tumor suppressorTatD DNase domain containing 2
SynonymsHRCA1|RCA1|VHL1|pVHL-
Cytomap

3p25.3

3p25.3

Type of geneprotein-codingprotein-coding
Descriptionvon Hippel-Lindau disease tumor suppressorelongin binding proteinprotein G7von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligaseputative deoxyribonuclease TATDN2
Modification date2018052320180519
UniProtAcc

P40337

Q93075

Ensembl transtripts involved in fusion geneENST00000256474, ENST00000345392, 
ENST00000477538, 
ENST00000287652, 
ENST00000448281, ENST00000496355, 
Fusion gene scores* DoF score3 X 3 X 2=183 X 3 X 2=18
# samples 44
** MAII scorelog2(4/18*10)=1.15200309344505
effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs).
DoF>8 and MAII>0
log2(4/18*10)=1.15200309344505
effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs).
DoF>8 and MAII>0
Context

PubMed: VHL [Title/Abstract] AND TATDN2 [Title/Abstract] AND fusion [Title/Abstract]

Functional or gene categories assigned by FusionGDB annotationTumor suppressor gene involved fusion gene, retained protein feature but frameshift.
DDR (DNA damage repair) gene involved fusion gene, in-frame but not retained their domain.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneVHL

GO:0016567

protein ubiquitination

24899725

HgeneVHL

GO:0061428

negative regulation of transcription from RNA polymerase II promoter in response to hypoxia

11641274


check button Fusion gene information from three resources
(ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018))
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
Data typeSourceCancer typeSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
TCGALDKIRCTCGA-B0-4700-01AVHLchr3

10183871

+TATDN2chr3

10311815

+
TCGALDKIRCTCGA-DV-5575-01AVHLchr3

10188320

+TATDN2chr3

10311815

+
* LD: Li Ding group's fusion gene list
  RV: Roel Verhaak group's fusion gene list
  ChiTaRs fusion database

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
Frame-shitENST00000256474ENST00000287652VHLchr3

10183871

+TATDN2chr3

10311815

+
Frame-shitENST00000256474ENST00000448281VHLchr3

10183871

+TATDN2chr3

10311815

+
5CDS-intronENST00000256474ENST00000496355VHLchr3

10183871

+TATDN2chr3

10311815

+
Frame-shitENST00000345392ENST00000287652VHLchr3

10183871

+TATDN2chr3

10311815

+
Frame-shitENST00000345392ENST00000448281VHLchr3

10183871

+TATDN2chr3

10311815

+
5CDS-intronENST00000345392ENST00000496355VHLchr3

10183871

+TATDN2chr3

10311815

+
intron-3CDSENST00000477538ENST00000287652VHLchr3

10183871

+TATDN2chr3

10311815

+
intron-3CDSENST00000477538ENST00000448281VHLchr3

10183871

+TATDN2chr3

10311815

+
intron-intronENST00000477538ENST00000496355VHLchr3

10183871

+TATDN2chr3

10311815

+
Frame-shitENST00000256474ENST00000287652VHLchr3

10188320

+TATDN2chr3

10311815

+
Frame-shitENST00000256474ENST00000448281VHLchr3

10188320

+TATDN2chr3

10311815

+
5CDS-intronENST00000256474ENST00000496355VHLchr3

10188320

+TATDN2chr3

10311815

+
intron-3CDSENST00000345392ENST00000287652VHLchr3

10188320

+TATDN2chr3

10311815

+
intron-3CDSENST00000345392ENST00000448281VHLchr3

10188320

+TATDN2chr3

10311815

+
intron-intronENST00000345392ENST00000496355VHLchr3

10188320

+TATDN2chr3

10311815

+
3UTR-3CDSENST00000477538ENST00000287652VHLchr3

10188320

+TATDN2chr3

10311815

+
3UTR-3CDSENST00000477538ENST00000448281VHLchr3

10188320

+TATDN2chr3

10311815

+
3UTR-intronENST00000477538ENST00000496355VHLchr3

10188320

+TATDN2chr3

10311815

+

Top

FusionProtFeatures for VHL_TATDN2


check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
VHL

P40337

TATDN2

Q93075

Involved in the ubiquitination and subsequentproteasomal degradation via the von Hippel-Lindau ubiquitinationcomplex. Seems to act as a target recruitment subunit in the E3ubiquitin ligase complex and recruits hydroxylated hypoxia-inducible factor (HIF) under normoxic conditions. Involved intranscriptional repression through interaction with HIF1A, HIF1ANand histone deacetylases. Ubiquitinates, in an oxygen-responsivemanner, ADRB2. {ECO:0000269|PubMed:10944113,ECO:0000269|PubMed:17981124, ECO:0000269|PubMed:19584355}. Putative deoxyribonuclease. {ECO:0000250}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page

.

* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note


Top

FusionGeneSequence for VHL_TATDN2


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences.
(nt: nucleotides, aa: amino acids)

* Fusion amino acid sequences.

* Fusion transcript sequences (only coding sequence (CDS) region).

* Fusion transcript sequences (Full-length transcript).

Top

FusionGenePPI for VHL_TATDN2


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page

.

check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors
VHLFLNA, VBP1, JADE1, CUL2, CAB39, TGFB1I1, STK16, PFAS, TCEB1, PSMB1, TCEB2, RHOC, CNTF, TXN, APRT, CDK2, PKD1L3, FSCN1, IARS, PSMB3, RASGRP1, RAB1B, RBX1, NEDD8, TAGLN2, MOB4, CCDC59, JMJD1C, CDO1, PAPSS2, HIST1H2BC, CCDC82, PSMD13, TARS, TPT1, RPA3, KNTC1, MCC, PCMT1, CSTB, CSTF3, HAS1, RPS9, IMPDH2, ATXN2, CHMP2B, MYL12A, PPIB, PIN1, PSMC3, HIF1A, ZNF197, TRIM28, HIF1AN, HDAC1, HDAC2, HDAC3, FN1, CUL5, HNRNPA2B1, USP33, RIT1, NR4A1, POLR2A, SAP130, EPAS1, OSR1, DGKZ, SAT2, CYBA, DNAJA3, IREB2, TP53, EP300, KAT2B, ATM, USP20, TCEB3, POLR2G, HIF3A, CCT3, MCM7, PRKCI, DVL2, MYBBP1A, UBXN7, ADRB2, SPRY2, ANKRD40, CDKN2A, STUB1, CMC2, DDX17, DDX3X, DDX3Y, DDX5, DNAJA1, DNAJA2, EPHA4, GRWD1, COLGALT1, HNRNPDL, HNRNPH1, HNRNPH2, HNRNPLL, HNRNPC, HNRNPD, HNRNPL, HNRNPM, HNRNPR, EIF5A, EIF5A2, NKRF, RALYL, RBBP4, RBBP7, RPL12, RPL14, RPL18A, HNRNPA3, RPS11, RPS14, RPS17, RPS27L, RPS27, RPS2, RPS3A, RPS3, RPSA, SNRNP70, TUBA1A, TUBA3C, TUBA3E, TUBA4A, TCP1, CCT2, CCT4, CCT5, CCT7, CCT8, CCT6A, TRAFD1, UBR5, PRMT3, ACTB, BSG, COL4A1, COL4A2, COL4A3, COL4A5, COL4A6, COL6A1, CRTAP, FASTKD3, GRN, HNRNPK, HNRNPU, HSPA8, MIF, IVNS1ABP, P3H1, PARP1, PLOD2, PLOD3, PPM1B, RPL10A, RPL30, RPL7A, RPLP0, HNRNPA1, HNRNPAB, RPS15A, RPS5, STK38, TUBA3D, TUBB4B, VHL, XRCC5, SKP2, CLU, ELAVL1, MYC, PIAS4, TOP2A, CBX5, BCL2L11, CSNK2A1, PRKCD, JAK2, SOCS1, SOCS3, LIMD1, EGLN1, AJUBA, WTIP, LPP, ZYX, COPS5, GNB2L1, PRKCH, PRKCZ, DGKI, KIF2C, SARNP, CAPN7, YY1AP1, RBPMS2, RB1CC1, FKBP8, PTPN14, EXOSC8, KIF3A, KIF3B, KIFAP3, HSPA1A, PARD6A, PARD3, KLF4, SP1, CARD9, RNF7, MKNK2, UBE2D1, ALAS1, CDC34, APP, DCUN1D1, TGM2, FZR1, PCGF2, ZNF512B, CHEK2, KAT5, RPS6, NOB1, RPL11, LTV1, PRMT1, MSH4, UXT, AR, SON, EEF1B2, RPL21, RBPMS, VAPB, NCL, SLC2A1, CD44, SLC3A2, HIST4H4, CBR1, HIST1H1C, CAPZB, HIST1H2BL, LANCL1, HSPA5, PRDX1, RPL5, CBX1, CBX3, PRMT8, ILF3, PDCD5, PARK7, AURKA, GLI1, E2F1, SIRT1, HSPA4, HSP90AA1, MDFI, PLD1, UBC, UBE2D2, C1QB, C1QTNF2, CER1, KIRREL2, BCL2L14, COL9A1, KNG1, ASTL, RWDD3, GOLGA4, TRIP12, ZNF350, ID2, ID1, ID3, PLD2, TARDBP, GPLD1, CERKL, EPOR, DACT1, DACT2, RHOBTB3, UBE2S, HUWE1, USP9X, SMURF1, MAP3K1, PRKDC, CDK4, TSC1, CHEK1, APC, CDKN1B, KDM5C, ARID2, PTEN, PDGFRA, BRAF, RRM2, ARID1A, MAP2K1, PIK3R1, FGFR3, SMARCB1, CDK6, ROR1, CASP8, PBRM1, RPS6KB1, FLT3, VEGFA, SQSTM1, CEP68, ATF7IP, SETDB1, ARL14EP, OXT, AVP, CHIT1, INHBE, C1QL4, UTRN, ACTBL2, FAM19A3, AKT1, AKT2, PPP2CA, FASN, CADTATDN2BRCA1, MOV10, NXF1, SPACA1, MRPL4, PLAUR, CCNJL, FBXW11


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

RelatedDrugs for VHL_TATDN2


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.0 2018-04-02)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status

Top

RelatedDiseases for VHL_TATDN2


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
HgeneVHLC0019562Von Hippel-Lindau Syndrome17CTD_human;ORPHANET;UNIPROT
HgeneVHLC0007134Renal Cell Carcinoma9CTD_human;HPO
HgeneVHLC0031511Pheochromocytoma9CTD_human;HPO;UNIPROT
HgeneVHLC1837915ERYTHROCYTOSIS, FAMILIAL, 25CTD_human;ORPHANET;UNIPROT
HgeneVHLC0001430Adenoma1CTD_human
HgeneVHLC0022665Kidney Neoplasm1CTD_human
HgeneVHLC0024121Lung Neoplasms1CTD_human
HgeneVHLC0027708Nephroblastoma1CTD_human
HgeneVHLC0279702Conventional (Clear Cell) Renal Cell Carcinoma1UNIPROT